A novel dynamic nomogram based on contrast-enhanced computed tomography radiomics for prediction of glypican-3-positive hepatocellular carcinoma

BackgroundThe 5-year overall survival of hepatocellular carcinoma (HCC) is still poor. Since glypican-3 (GPC3) is highly expressed in most HCC but not in healthy or non-malignant livers, it may become an ideal therapeutic target for HCC. Thus, this study aimed to construct a dynamic nomogram based o...

全面介紹

書目詳細資料

Principais autores:	Chunlong Zhao, Zheyu Zhou, Jiarun Zhang, Shuya Cao, Jiawei Xu, Cheng Wang, Jun Chen, Xiaoliang Xu, Chaobo Chen, Bing Han
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2025-10-01
叢編:	Frontiers in Oncology
主題:	hepatocellular carcinoma glypican-3 radiomics computed tomography prediction
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1640697/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!